Ortho-Clinical plans new debt financing for buyout by Carlyle Group

By Sara Rosenberg

New York, Jan. 16 - Ortho-Clinical Diagnostics plans has received a commitment for new debt to help fund its purchase by the Carlyle Group from Johnson & Johnson, according to a news release.

Barclays, Goldman Sachs, Credit Suisse, UBS and Nomura are leading the debt.

Other funds for the transaction will come from equity.

Under the agreement, Ortho-Clinical Diagnostics is being acquired for $4.15 billion.

Closing is expected in the middle of this year, subject to customary regulatory approvals.

Ortho-Clinical Diagnostics is a Raritan, N.J.-based provider of solutions for screening, diagnosing, monitoring and confirming diseases.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.